FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to drugs and concerns using (2R,4R)-2-({[5-(4-fluorophenyl)-pyridin-3-ylmethyl]-amino}-methyl)-chroman-4-ol or its pharmaceutically acceptable salts or solvates used for production of a drug for treatment of catalepsy. Also, invention proposes a pharmaceutical composition for treatment of catalepsy that comprises (2R,4R)-2-({[5-(4-fluorophenyl)-pyridin-3-ylmethyl]-amino}-methyl)-chroman-4-ol as an active component taken in the pharmaceutically effective amount in combination with one or some pharmaceutically acceptable excipients.
EFFECT: valuable medicinal properties of compound and pharmaceutical composition.
3 cl, 15 ex
Title |
Year |
Author |
Number |
NOVEL USING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS |
2002 |
- Bartoshik Gerd
- Russ Germann
- Zejfrid Kristof
- Veber Frank
|
RU2297833C2 |
METHODS FOR TREATMENT OF BEHAVIOR CHANGES |
2018 |
- Maes, Tamara
- Rotllant Pozo, David
- Grinan Ferre, Christian
- Pallas Lliberia, Merce
- Nadal Alemany, Roser
- Almario Garcia, Antonio
|
RU2799049C2 |
CHROMON OXIME NEW DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS |
2015 |
- Charvin, Delphine
- Manteau, Baptiste
- Pomel, Vincent
- Conquet, Francois
|
RU2672569C2 |
3R,4S 3-[4-(4-FLUOROPHENYL)-4-HYDROXYPIPERIDIN-1- YL)CHROHAN-4,7-DIOL, OPTICAL ISOMERS THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT |
1994 |
- Todd V.Batler
- Bertrand L.Chenard
|
RU2126404C1 |
SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO [3_2_0] HEPT-3-EN-6-ONE |
2016 |
- Ford Rhonan Lee
- Meghani Premji
|
RU2734475C2 |
SYNERGETIC TREATMENT OF PARKINSONISM |
1995 |
- Bertran L. Chenard
- Frank S. Menniti
|
RU2176145C2 |
NOVEL USING SUBSTITUTED AMINOMETHYLCHROMANS IN TREATMENT OF MOTION DISORDER OR UNDESIRABLE EFFECT CAUSED BY AGENTS THAT ARE ADMINISTRATED IN TREATMENT OF EXTRAPYRAMID MOTION DISORDER |
2002 |
- Bartoshik Gerd
- Russ Germann
- Zejfrid Kristof
- Bettkher Khenning
- Bokel' Khajnts-Germann
- Shmid-Grossmann Ushi
|
RU2320336C2 |
NOVEL SALT FORM OF DOPAMINE AGONIST |
2006 |
- Grin Stjuart Piter
- Ladzari Oliv'E Alen
- Miller Dunkan Charl'Z
- Saling Fabris Genri
|
RU2393153C2 |
7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZIOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(PROPYNYL)-7H-PYRAZOLO-[4, 3-e]-[1, 2, 4]-TRIAZOLO-[1, 5-c]PYRIMIDINE-5-AMINE |
2006 |
- Bojl Krejg D.
- Chakkalamannil Samjuehl'
- Shakh Unmesh G.
- Lakhovich Zhan Eh.
|
RU2417997C2 |
COMBINED THERAPY BASED ON CD20 ANTIBODY COMBINED WITH BCL-2 INHIBITOR AND MDM2 INHIBITOR |
2016 |
- Klyajn Kristian
- Kherting Frank
- Dangl Markus
|
RU2727196C2 |